(3S,4R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,4R)-4,6-diamino-2-[(3S,4R,5R)-4-[(6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-[[4-[4-[1-[6-[4-[[4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]phenoxy]methyl]triazol-1-yl]hexyl]triazol-4-yl]butyl]triazol-1-yl]methyl]oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
C58H89N19O13 — CID 122691419
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S,4R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,4R)-4,6-diamino-2-[(3S,4R,5R)-4-[(6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-[[4-[4-[1-[6-[4-[[4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]phenoxy]methyl]triazol-1-yl]hexyl]triazol-4-yl]butyl]triazol-1-yl]methyl]oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
(3S,4R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,4R)-4,6-diamino-2-[(3S,4R,5R)-4-[(6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-[[4-[4-[1-[6-[4-[[4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]phenoxy]methyl]triazol-1-yl]hexyl]triazol-4-yl]butyl]triazol-1-yl]methyl]oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol (PubChem CID 122691419) has the molecular formula C58H89N19O13 and a molecular weight of 1260.47 g/mol. Its IUPAC name is (3S,4R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,4R)-4,6-diamino-2-[(3S,4R,5R)-4-[(6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-[[4-[4-[1-[6-[4-[[4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]phenoxy]methyl]triazol-1-yl]hexyl]triazol-4-yl]butyl]triazol-1-yl]methyl]oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol.
Molecular Properties
| Compound Name | (3S,4R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,4R)-4,6-diamino-2-[(3S,4R,5R)-4-[(6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-[[4-[4-[1-[6-[4-[[4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]phenoxy]methyl]triazol-1-yl]hexyl]triazol-4-yl]butyl]triazol-1-yl]methyl]oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol |
|---|---|
| PubChem CID | 122691419 |
| Molecular Formula | C58H89N19O13 |
| Molecular Weight | 1260.47 g/mol |
| Exact Mass | 1259.69 |
| IUPAC Name | (3S,4R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,4R)-4,6-diamino-2-[(3S,4R,5R)-4-[(6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-[[4-[4-[1-[6-[4-[[4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]phenoxy]methyl]triazol-1-yl]hexyl]triazol-4-yl]butyl]triazol-1-yl]methyl]oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol |
| SMILES | CN1CCN(c2ccc3nc(-c4ccc(OCc5cn(CCCCCCn6cc(CCCCc7cn(C[C@H]8OC(O[C@@H]9C(O)[C@H](N)CC(N)[C@H]9O[C@H]9OC(CN)[C@@H](O)[C@H](O)C9N)[C@@H](O)[C@H]8OC8O[C@@H](CN)C(O)C(O)C8N)nn7)nn6)nn5)cc4)[nH]c3c2)CC1 |
| InChI | InChI=1S/C58H89N19O13/c1-73-18-20-74(21-19-73)35-12-15-39-40(22-35)66-55(65-39)31-10-13-36(14-11-31)84-30-34-28-76(71-69-34)17-7-3-2-6-16-75-26-32(67-70-75)8-4-5-9-33-27-77(72-68-33)29-43-53(89-57-45(64)50(82)48(80)42(25-60)86-57)51(83)58(87-43)90-54-46(78)37(61)23-38(62)52(54)88-56-44(63)49(81)47(79)41(24-59)85-56/h10-15,22,26-28,37-38,41-54,56-58,78-83H,2-9,16-21,23-25,29-30,59-64H2,1H3,(H,65,66)/t37-,38?,41?,42+,43-,44?,45?,46?,47-,48?,49-,50?,51+,52-,53+,54-,56-,57?,58?/m1/s1 |
| InChIKey | BXPLQKUWDFUFRK-ICZDXTPMSA-N |
| XLogP | -3.71 |
| TPSA | 469.40 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 90 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1260.47 |
| LogP ≤ 5 | -3.71 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 31 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122691419 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.